Francisco Javier Cabrera A

Prof. Dr. Francisco Javier Cabrera A

Veterinary Medicine School, Universidad San Francisco de Quito, Quito, Pichincha, Ecuador
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Stem Cells International
Verified
Journal Article
Open access
PDF file
Andrés CaicedoAndrés Caicedo
Andrés Caicedo
Pedro ApontePedro Aponte
Pedro Aponte
Francisco Javier Cabrera AFrancisco Javier Cabrera A
Francisco Javier Cabrera A
CHCarmen Hidalgo
Carmen Hidalgo
MKMaroun Khoury
Maroun Khoury
The objective of this review is to outline existing artificial mitochondria transfer techniques and to describe the future steps necessary to develop new therapeutic applications in medicine. Inspired by the symbiotic origin of mitochondria and by the cell’s capacity to transfer these organelles to damaged neighbors, many researchers have developed procedures to artificially transfer mitochondria from one cell to another. The techniques currently in use today range from simple coincubations of isolated mitochondria and recipient cells to the use of physical approaches to induce integration. These methods mimic natural mitochondria transfer. In order to use mitochondrial transfer in medicine, we must answer key questions about how to replicate aspects of natural transport processes to improve current artificial transfer methods. Another priority is to determine the optimum quantity and cell/tissue source of the mitochondria in order to induce cell reprogramming or tissue repair, in both in vitro and in vivo applications. Additionally, it is important that the field explores how artificial mitochondria transfer techniques can be used to treat different diseases and how to navigate the ethical issues in such procedures. Without a doubt, mitochondria are more than mere cell power plants, as we continue to discover their potential to be used in medicine.

28 June 2019 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
Francisco Javier Cabrera AFrancisco Javier Cabrera A
Francisco Javier Cabrera A
MOMayra Ortega
Mayra Ortega
FVFrancesca Velarde
Francesca Velarde
EPEliseo Parra
Eliseo Parra
SGStephany Gallardo
Stephany Gallardo
Andrés CaicedoAndrés Caicedo
Andrés Caicedo
Artificial Mitochondrial Transfer or Transplant (AMT/T) can be used to reduce the stress and loss of viability of damaged cells. In MitoCeption, a type of AMT/T, the isolated mitochondria and recipient cells are centrifuged together at 4 °C and then co-incubated at 37 °C in normal culture conditions, inducing the transfer. Ultraviolet radiation (UVR) can affect mitochondria and other cell structures, resulting in tissue stress, aging, and immunosuppression. AMT/T could be used to repair UVR cellular and mitochondrial damage. We studied if a mitochondrial mix from different donors (Primary Allogeneic Mitochondrial Mix, PAMM) can repair UVR damage and promote cell survival. Using a simplified adaption of the MitoCeption protocol, we used peripheral blood mononuclear cells (PBMCs) as the recipient cell model of the PAMM in order to determine if this protocol could repair UVR damage. Our results showed that when PBMCs are exposed to UVR, there is a decrease in metabolic activity, mitochondrial mass, and mtDNA sequence stability as well as an increase in p53 expression and the percentage of dead cells. When PAMM MitoCeption was used on UVR-damaged cells, it successfully transferred mitochondria from different donors to distinct PBMCs populations and repaired the observed UVR damage. Our results represent an advancement in the applications of MitoCeption and other AMT/T. We showed that PBMCs could be used as a PAMM source of mitochondria. We also showed that these mitochondria can be transferred in a mix from different donors (PAMM) to UVR-damaged, non-adherent primary cells. Additionally, we decreased the duration of the MitoCeption protocol.

Verified
Journal Article
Open access
PDF file
IYInti Yuyari Yamberla
Inti Yuyari Yamberla
CPCarla Mireya Pupiales
Carla Mireya Pupiales
Andrea Jazmín ChiliquingaAndrea Jazmín Chiliquinga
Andrea Jazmín Chiliquinga
TSTania Salomé Sulca-Villamarín
Tania Salomé Sulca-Villamarín
APAlejandra Jacqueline Plasencia
Alejandra Jacqueline Plasencia
PBPedro Miguel Barba
Pedro Miguel Barba
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen frequently associated with delayed wound healing, particularly in chronic skin injuries. Its capability to form biofilms, secrete virulence factors, and the faculty to compete with other microorganisms makes it a major challenge in clinical wound management. Recent literature reveals different molecular and cellular mechanisms through which P. aeruginosa disrupts the wound healing process. Findings highlight that it interferes with key phases of healing by modulating host immune responses, degrading extracellular matrix components, and inhibiting keratinocyte migration. Its quorum-sensing systems regulate the expression of critical virulence factors such as exotoxin A, elastases, pyocyanin, and rhamnolipids. Additionally, the production of the biofilm matrix components alginate, and polysaccharides provide protection against host defenses and antibiotics. Interactions with other microorganisms, including antagonistic effects on Staphylococcus epidermidis and synergistic relationships with Staphylococcus aureus, modify the wound microbiota. Promising therapeutic alternatives have shown efficacy in disrupting biofilms and reducing virulence. These insights remark the importance of targeting both P. aeruginosa and its ecological interactions to enhance wound healing outcomes and develop more effective treatments. This review aimed to highlight the pathogenic role of P. aeruginosa and its interactions with other microbial species in the context of skin wound healing.

29 August 2022 in Cytotherapy
Verified
Journal Article
Closed access
ALAriana León-Sosa
Ariana León-Sosa
VCVerónica Castañeda
Verónica Castañeda
RERoberto Espinosa-Vallejo
Roberto Espinosa-Vallejo
XGXavier Gómez
Xavier Gómez
RDRamiro F. Díaz
Ramiro F. Díaz
Andrés CaicedoAndrés Caicedo
Andrés Caicedo

1 September 2021 in Veterinary and Animal Science
Verified
Journal Article
Open access
AVA. Villagomez
A. Villagomez
TBT. Borja
T. Borja
PPP. Pontón
P. Pontón
GSG. Segnini
G. Segnini
PBP. Barba
P. Barba
Andrés CaicedoAndrés Caicedo
Andrés Caicedo
• Incisional wound closure is a critical surgical step to facilitate tissue healing. • Cyanoacrylates (Histoacryl®) have become a popular veterinary wound closure practice. • Effects of Histoacryl® over traditional suture on wounds rest undetermined. • Histoacryl® vs. Poliglecaprone (Monocryl®) have similar regenerative results in mice. • Histoacryl® or Monocryl® could be used to treat wounds in rodents.

15 March 2025 in Anatomia, Histologia, Embryologia
Verified
Journal Article
Closed access
Francisco Javier Cabrera AFrancisco Javier Cabrera A
Francisco Javier Cabrera A
EDE. M. Delgado‐Ruilova
E. M. Delgado‐Ruilova
CSC. Sáenz
C. Sáenz
BOB. A. Ordoñez
B. A. Ordoñez